News & Insights

By Myassa Kjaerem,

Senior Global Medical Advisor, MD. PhD:

With my background in oncology research, I recognize the complexity of cancer and the profound impact the disease has on patients and their loved ones.

Copenhagen, January 29th, 2025 – AJ Vaccines today announces the decision to phase out its Polio (Picovax) production as part of its strategy to ensure a sustainable and competitive future. This decision was made in response to unfavorable market conditions and significant financial challenges associated with Polio vaccine production.

Patient safety is a fundamental priority in healthcare, centered on protecting patients from harm and ensuring that care is delivered in the safest possible way.

The ongoing challenge of polio, especially in regions facing crises, was a key topic in a recent interview on Radio IIII with our Medical Director, Hans-Henrik Christensen.